We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$260M
AUM Growth
+$22M
Cap. Flow
+$12.7M
Cap. Flow %
4.88%
Top 10 Hldgs %
34.67%
Holding
391
New
8
Increased
34
Reduced
90
Closed
22

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$943K
2
ADBE icon
Adobe
ADBE
+$778K
3
CELG
Celgene Corp
CELG
+$554K
4
BIIB icon
Biogen
BIIB
+$498K
5
IMO icon
Imperial Oil
IMO
+$400K

Sector Composition

Rank Sector Weight
1 Technology 17.95%
2 Miscellaneous 17.52%
3 Healthcare 15.33%
4 Consumer Staples 14.14%
5 Energy 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLY icon
26
John Wiley & Sons Class A
WLY
$2.73B
$3.15M 1.21%
60,445
-725
-1% -$36.6K
ADP icon
27
Automatic Data Processing
ADP
$114B
$3.02M 1.16%
32,931
-110
-0.3% -$9.71K
SYK icon
28
Stryker
SYK
$127B
$2.93M 1.13%
24,445
-739
-3% -$82.6K
TRP icon
29
TC Energy
TRP
$64.4B
$2.63M 1.01%
58,161
-2,600
-4% -$107K
AWH
30
DELISTED
Allied World Assurance Co Hld Lt
AWH
$2.48M 0.95%
70,525
+3,825
+6% +$138K
DD
31
DELISTED
Du Pont De Nemours E I
DD
$2.43M 0.93%
37,468
-2,025
-5% -$133K
MRK icon
32
Merck
MRK
$366B
$2.41M 0.93%
43,923
-3,087
-7% -$164K
TFX icon
33
Teleflex
TFX
$5.92B
$2.3M 0.88%
12,984
-300
-2% -$48.9K
WFC.PRJ.CL
34
DELISTED
Wells Fargo & Company
WFC.PRJ.CL
$2.21M 0.85%
79,650
+10,400
+15% +$291K
KO icon
35
Coca-Cola
KO
$386B
$2.16M 0.83%
47,687
-800
-2% -$36.2K
SFE
36
DELISTED
Safeguard Scientifics, Inc.
SFE
$2.13M 0.82%
170,866
+20,100
+13% +$270K
FFIV icon
37
F5
FFIV
$22.3B
$2.1M 0.81%
18,430
-250
-1% -$26.9K
TD icon
38
Toronto Dominion Bank
TD
$199B
$2.02M 0.78%
47,036
USB.PRM
39
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
$1.85M 0.71%
60,100
+6,350
+12% +$191K
GNTX icon
40
Gentex
GNTX
$4.78B
$1.81M 0.7%
117,275
-5,300
-4% -$84.2K
BRK.B icon
41
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.8M 0.69%
12,415
LQD icon
42
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$1.76M 0.68%
14,360
-710
-5% -$85.2K
T icon
43
AT&T
T
$178B
$1.73M 0.66%
52,977
MKC icon
44
McCormick & Company Non-Voting
MKC
$14.9B
$1.73M 0.66%
32,390
+2,230
+7% +$109K
BIIB icon
45
Biogen
BIIB
$32.3B
$1.65M 0.63%
6,815
+1,890
+38% +$498K
IBB icon
46
iShares Biotechnology ETF
IBB
$10.5B
$1.48M 0.57%
17,295
-1,155
-6% -$104K
CELG
47
DELISTED
Celgene Corp
CELG
$1.47M 0.56%
14,855
+5,360
+56% +$554K
XBI icon
48
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$1.46M 0.56%
27,005
-1,345
-5% -$73.7K
IMO icon
49
Imperial Oil
IMO
$63.1B
$1.39M 0.53%
43,960
+12,620
+40% +$400K
FBIN icon
50
Fortune Brands Innovations
FBIN
$5.43B
$1.34M 0.52%
27,114
-526
-2% -$25.7K

Similar funds

American Research & Management Company's Q2 2016 Portfolio in Review

As of Q2 2016, American Research & Management Company held 391 positions worth $260M, up 9.3% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

American Research & Management Company deployed $12.7M of net new capital in Q2 2016, opening 8 new positions and adding to 34 existing holdings. Its largest new stake was Edwards Lifesciences: 3,900 shares worth $130K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was PRA Group, an estimated $738K trimmed.

  • American Research & Management Company's largest Q2 2016 buy was Edwards Lifesciences: 3,900 shares worth $130K.
  • American Research & Management Company added most to IBM in Q2 2016, an estimated $943K increase.
  • American Research & Management Company's biggest Q2 2016 reduction was PRA Group, cutting an estimated $738K.
  • American Research & Management Company fully exited RBS CAPITAL FUNDING TRUST VII GTD TR PFD SEC 6.08% in Q2 2016, selling an estimated $442K.
  • American Research & Management Company's ten largest holdings make up 35% of its $260M portfolio in Q2 2016.
  • American Research & Management Company opened 8 new positions and closed 22 in Q2 2016.
  • American Research & Management Company's portfolio value rose 9.3% quarter-over-quarter to $260M.

Based on American Research & Management Company's 13F filing for Q2 2016, filed 29 Jul 2016.